General meetings

Documents for downloading, related to General Meetings of Xspray Pharma AB (publ)

Annual general meeting 21 May 2024

Xspray Pharmas’ Annual General Meeting 2024 will be held at 10:00 CEST on Tuesday, 21 May 2024 at Advokatfirman Vinge’s office on Smålandsgatan 20 in Stockholm, Sweden.
Notice of annual general meeting 21 May 2024
Proxy form
Attendance and voting form
Proposal and motivated statement of the Nomination Committee
Remuneration report 2023
The Auditors statement
The Board of Directors complete proposal regarding long term incentive program LTIP 2024
Terms and Conditions of LTIP 2024
Minutes AGM 21 May 2024

Extraordinary general meeting 25 May 2023

Xspray Pharmas’ Annual General Meeting 2023 will be held at 13:00 CEST on Tuesday, 25 May 2023 at Advokatfirman Vinge’s office on Smålandsgatan 20 in Stockholm, Sweden.
Notice of Extraordinary general meeting, May 25, 2023
EGM Proxy form
EGM Attendance and voting form

Annual general meeting 16 May 2023

Xspray Pharmas’ Annual General Meeting 2023 will be held at 10:00 CEST on Tuesday, 16 May 2023 at Advokatfirman Vinge’s office on Smålandsgatan 20 in Stockholm, Sweden.
Notice of annual general meeting 16 May 2023
Proxy form
Attendance and voting form
Proposal and motivated statement of the Nomination Committee
Remuneration report 2022
The Board of Directors´complete proposal regarding long term incentive program LITP 2023
The Auditors’ statement
Minutes AGM 2023 05 16

Annual general meeting 19 May 2022

Notice of annual general meeting 19 May 2022
Proxy form
Attendance and advanced voting form
Proposal and motivated statement of the Nomination Committee 
The Board of Directors’ complete proposal regarding long term incentive program LTI 2022
Terms and conditions of LTI 2022
The board of directors’ proposal to amend the Articles of Association
Minutes AGM 2022 05 19

Annual general meeting 20 May 2021

Notice of annual general meeting 20 May 2021
Proxy form
Attendance and advanced voting form
Proposal and motivated statement of the Nomination Committee
The Board of Director’s of Xspray Pharma (publ) proposal for warrant programme LTIP 2021 (staff)
Terms and conditions of the LTIP 2021 (staff)
The Nomination Committee of Xspray Pharma (publ) proposal for warrant programme LTIP 2021 (Chairman of the Board)
Terms and conditions of the LTIP 2021 (Chairman of the Board)
The board of directors’ proposal to amend the Articles of Association
Minutes AGM 2021 05 20

Annual general meeting 14 May 2020

CEO Speach at annual general meeting 14 May 2020
Notice of annual general meeting of Xspray Pharma AB (publ)
Attendance and advanced voting form
Proxy form
Proposal and motivated statement of the Nomination Committee
Minutes AGM 2020 05 14

Extraordinary general meeting March 26, 2020

Notice of extraordinary general meeting of Xspray Pharma AB (publ)
The Board of Directors of Xspray Pharma AB (publ) proposal for warrant programme_LTI 2020-2023
Terms and conditions of the LTI 2020-2023
The Board´s statement in accordance with Chapter 14 Section 8 of the Swedish Companies Act
Auditors opinion under Chapter 14 Section 8 of the Swedish Companies Act
AGM 2020 – Proxy form
Minutes EGM 2020 03 26

Annual general meeting 23 May 2019

Notice of annual general meeting of Xspray Pharma AB (publ)
AGM 2019 – Proxy form
The nomination committee’s proposal and motivated statement

Extraordinary general meeting November 28 2018

Xspray Pharma – Notice EGM 2018[1]
EGM 2018 Fullmaktsformulär Eng – Proxy-form
XSpray Pharma – Terms and conditions of the warrants
The Board´s statement in accordance with Chapter 14 Section 8 of the Swedish Companies Act
Auditors Opinion under Chapter 14 Section 8 of the Swedish Companies Act

Annual general meeting May 14 2018

Notice to Annual General Meeting in Xspray Pharma AB (publ)
AGM_2018 – Proxy form

Extraordinary general meeting February 20 2018

Notice of extraordinary general meeting in Xspray Pharma AB (publ) February 20
The Board of Directors’ statement in accordance with Chapter 13 Section 6 of the Swedish Companies Act
Auditor’s opinion under Chapter 13 Section 6 the Companies Act (2005: 551) on the Board of Directorss statement of significant events for the period 2017-03-31 – 2018-01-30
The Board of Director’s of Xspray Pharma AB (publ) proposal for a resolution on a directed issue of shares
Proxy form